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Abstract
Background and Purpose: Renal hematoma after ureteroscopic lithotripsy (URSL) using holmium:yttrium-
aluminum-garnet (Ho:YAG) laser is a rare complication. We aimed to review our center’s experience of
post-URSL subcapsular hematoma.
Patients and Methods: From 2007 to 2012, 1114 URSLs using 7.5F semi-rigid ureteroscopes were performed.
Patients with post-URSL symptomatic renal hematoma were reviewed. Perioperative information on patients’
preoperative morbidity, renal function, stone characteristics, and degree of hydronephrosis were reviewed.
Operative information, postoperative presentation of symptoms, changes in blood parameters, CT findings, and
subsequent management were documented.
Results: Post-URSL subcapsular hematoma was diagnosed in 4 of 1114 (0.36%) patients, who ranged in age from
43 to 63 years. Preoperative imaging showed that all four patients had obstructing proximal ureteral stones
ranging in size from 0.7 to 2.1 cm, and three of them had thin renal cortices. Pressure bags were not used, and
Double-J ureteral stents were inserted in all cases. All four patients had the triad of loin pain, fever, and
significant hemoglobin drop necessitating transfusion. Three patients presented within 2 days of URSL, and one
patient presented on day 20. One patient was treated conservatively and recovered with bed rest and antibiotics.
Urgent angiography was performed on one patient in view of a significant drop in hemoglobin, but no em-
bolization was needed. One patient underwent ultrasonography-guided drainage of the hematoma, and another
had an emergency open clot evacuation because of significant compression on the kidney by the hematoma.
Follow-up CT scans confirmed the resolution of the hematoma in all cases.
Conclusions: Post-URSL subcapsular hematoma is a rare but potentially serious complication. A high index of
suspicion is needed when patients present with significant loin pain and fever after URSL for obstructing
proximal ureteral stones with thin renal cortices. The management of post-URSL subcapsular hematomas needs
to be customized for each patient.
Introduction
Ureteroscopic lithotripsy (URSL) with holmium:yttrium-aluminum-garnet (Ho:YAG) laser is effective
and safe for managing ureteral stones,1 and is one of the most
common procedures in urology. Given the development of
smaller caliber ureteroscopes and the refinement of endo-
scopic techniques, complication rates are generally regarded
as low. Major complications occur in fewer than 0.1% of
cases.2 Among the major complications, renal hematoma after
URSL has only been reported in two case reports and one case
series.3–5 Nuttall and associates2 reviewed 48 studies on URSL
complications that covered 4454 URSLs and found only one
case of perinephric hematoma.
We believe that more attention to this rare but potentially
serious complication is warranted. Consequently, we con-
ducted a detailed analysis of our cases of subcapsular and
perinephric hematoma after URSL with Ho:YAG laser. The
presentation, common characteristics, and customized man-
agement of each case are discussed.
Patients and Methods
All URSLs performed in our center from January 2007 to
March 2012 were retrospectively reviewed, and cases with
post-URSL subcapsular hematoma were identified and studied
in detail. Patient demographics, stone characteristics on CT or
intravenous urography (IVU), the presence of hydronephrosis,
intraoperative findings, presentation of renal hematoma, and
treatment of each patient were documented and compared.
URSL was performed with a 7.5F semi-rigid nonirrigating
ureteroscope under general anesthesia. A 0.035-inch Terumo
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safety guidewire and an 8F infant feeding tube for bladder
drainage were used in every case. The ureteroscope was in-
troduced into the ureter without dilation under direct vision
and/or fluoroscopic guidance. The irrigating saline solution
was positioned 80 cm above the patient. A 0.365lm Ho:YAG
laser fiber was used for lithotripsy, and the energy setting was
set at 0.6 to 1.0 J at a rate of 6 to 10 Hz. Laser fragmentation of
stones was performed until they were in 1-2 mm fragments. A
6F or 7F Double-J stent was inserted and kept in for 4 to 6
weeks most of the time, according to the decision of the sur-
geon. Patients without fever or loin pain were usually dis-
charged within 24 to 36 hours after the procedure.
For patients with persistent fever or loin pain or necessi-
tating readmission, continued antibiotic therapy and close
monitoring were enforced. If accompanied by a concomitant
drop in hemoglobin not attributable to other causes, the pain
and fever were suspected to be procedure-related and CT
urography with contrast was performed to confirm the di-
agnosis of renal hematoma. Individualized treatment was
adopted according to the patient’s vital signs and response to
medical therapy.
Results
Of the 1114 URSLs performed in the 5-year period, 4
(0.36%) cases of subcapsular hematoma were identified (Table
1). The four patients were two men and two women between
43 and 63 years of age. Three of the patients were obese with a
body mass index (BMI) > 25 kg/m2. The serum creatinine le-
vel before URSL was normal in three patients and mildly
impaired in one (158 lmol/L). Preoperative serum platelet
level and International Normalized Ratio were all normal. No
patient was receiving antiplatelet or anticoagulant medica-
tion. Regarding the stone characteristics, all were radiopaque
obstructive upper ureter stones ranging from 0.7 to 2.1 cm,
associated with mild to severe hydronephrosis. Fever, loin
pain, and a significant drop in hemoglobin level (3–5 g/dL)
were the presenting symptoms in all four patients, and all of
Table 1. Clinical Details of the Four Patients with Postureteroscopic Lithotripsy Renal Hematomas
Patient 1 Patient 2 Patient 3 Patient 4
Age/sex 63/M 50/F 63/F 43/F
BMI 27.3 22.7 27.2 39.3
Medical history Hypertension, bilateral
renal stones, prostate
cancer pending
prostatectomy
Good past health Hypertension,
diabetes
Hyperlipidemia,
asthma,
endometriosis
Baseline serum
creatinine
(lmol/L)
66 158 70 69
Location Proximal (left) Proximal (right) Proximal (right) Proximal (right)
Size 1.5 cm 2.1 cm 2.1 cm 0.7 cm
Hydronephrosis Severe Severe Severe Mild
Renal cortex Thin Thin 1cm Thin 1 cm Normal 2.8 cm
Procedure
duration
150 min 95 min 66 min 30 min
Double-J stent
size
F 7 F 7 F 6 F 6
Residual stone Stone clearance 1 cm renal stone Multiple renal stones 5 mm renal stone
Intraoperative
findings
Tight ureteral orifice
and tortuous ureter
Tightly impacted
stone
Tortuous ureter and
tightly impacted
stone
Tortuous ureter, o
ureteral stone seen
Presentation day Day 1 Day 2 Day 2 Day 20
Postoperative
presentation
Hematuria, loin pain,
fever
Fever, loin pain Fever, loin pain Fever, loin pain
CT findings 10.5 · 5.5 · 18 cm
subcapsular
hematoma
2.6 · 8.2 · 10 cm
subcapsular
hematoma
7· 9.5 · 11cm
subcapsular
hematoma
20· 10· 10 cm
subcapsular
hematoma
Hb drop from
baseline
4.4 g/dL 3 g/dL 5 g/dL 5 g/dL
Packed cells
transfusion
2 units 2 units 2 units 2 units
Progress Fever and symptom
subside
Persistent fever Further drop of Hb Potential Page kidney
Management Conservative Ultrasonography
guided drainage of
10 mL hematoma
Angiogram: No
significant contrast
extravasation; no
embolization done
Open evacuation of
500 mL hematoma
Hospital stay 14 days 13 days 12 days 59 days
Creatinine on FU 70 182 66 71
BMI= body mass index; CT= computed tomography; Hb=hemoglobin; FU= follow-up.
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them needed blood transfusion and continued antibiotic
therapy. Three patients presented early, within 2 days after
URSL, while one had a delayed presentation on day 20. The
three patients who presented early all had a thin renal cortex,
impacted ureteral stone, tortuous ureter, and prolonged op-
eration lasting more than 60 minutes. A flexible ureteroscope
was used in one patient because of the tortuosity of the ureter.
The treatment plan for all patients differed according to
their clinical situation. Patient 1 was treated conservatively
with antibiotics and bed rest because he remained hemody-
namically stable with a static hemoglobin level after the initial
drop, and no active contrast extravasation was depicted on
CT. Patient 2 (Fig. 1) had persistent fever, and a pigtail drain
was inserted to drain the subcapsular hematoma under ul-
trasonography guidance on day 8. Her fever subsided soon
after drainage, and she was discharged on day 12. A follow-
up CT scan at 5 weeks showed complete resolution of the
hematoma. Patient 3 had a further drop in hemoglobin level
after confirmation of the subcapsular hematoma on CT. Ur-
gent angiography was performed, which revealed no signif-
icant contrast extravasation, and embolization was not
performed.
Patient 4 had delayed presentation and was readmitted for
fever and loin pain on day 20. Blood tests revealed a 5 g/dL
drop in serum hemoglobin level compared with the preop-
erative level. A CT scan showed significant compression of
the kidney by a hematoma measuring 20· 10· 10 cm (Fig. 2).
With the concern of a Page kidney, open evacuation of the
hematoma was performed, and 500 mL of blood clots were
evacuated. Follow-up CT after 3 weeks showed a small peri-
nephric abscess, and ultrasonography-guided aspiration was
performed. A subsequent CT 2 months later confirmed the
resolution of perinephric collection.
The three patients without need of open surgery were
discharged within 2 weeks, while the patient with open
evacuation stayed for almost 2 months. All four patients re-
covered well with no significant deterioration in renal func-
tion, and all hematomas had resolved by the time of the
follow-up scans.
Discussion
While subcapsular hematoma has been thoroughly studied
and reported as a complication after extracorporeal shock-
wave lithotripsy (SWL), its occurrence is far less common after
URSL. Despite its rare occurrence, this disease warrants par-
ticular attention because it has potentially serious sequelae for
kidney function and can easily be missed if a high index of
suspicion is not maintained. This article describes the pre-
sentation and management of our series of four rare cases of
renal hematoma after URSL. The overall incidence of 0.36% in
our series was very similar to the other case series recently
reported in Wuhan, China.3 In their series, Bai and colleagues3
reported 11 (0.4%) subcapsular hematomas after 2848 URSLs
using the Ho:YAG laser, and described the risk factors for the
development of hematoma. To the best of our knowledge,
ours is the second series in the English-language literature
after that of Bai and colleagues.3 Table 2 summarizes the
published reports on subcapsular hematoma after URSL.
The presentation of subcapsular hematoma after URSL is
similar to that after SWL. All four of our patients presented
with loin pain and fever. In the two single case reports4,5 and
the series by Bai and coworkers,3 the chief complaint was loin
pain. Most patients also presented with fever and a palpable
loin mass. Other associated symptoms included hematuria,
diffuse abdominal pain, and hypotension. Because patients
undergoing uneventful URSL are expected to recover quickly
and become ambulatory within a day of the procedure,
these signs and symptoms should alert the attending phy-
sician to look for any signs of serious complications. Differ-
ential diagnoses would include sepsis, incomplete stone
FIG. 1. Patient with ultrasonography-guided drainage of
hematoma performed.
FIG. 2. Patient with open evacuation of hematoma for
potential Page kidney
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fragmentation with persistent obstruction, or subcapsular
hematoma. The presence of a significant hemoglobin drop
would strongly suggest the diagnosis of subcapsular hema-
toma.
The etiology underlying the complication of subcapsular
hematoma has not been well defined. Bansal and associates4
suggested that the most probable explanation for the devel-
opment of hematoma could be trauma to the pelvicaliceal
system during guidewire manipulation, or raised intrarenal
pressure leading to forniceal rupture and separation of the
capsule from the parenchyma and hematoma. Bai and co-
workers3 showed that larger stone size (1.4 vs 0.9 cm), more
severe ipsilateral hydronephrosis, longer operation duration
(41 vs 33 min), and higher perfusion pressure of hydraulic
irrigation (176.8 vs 170.2 mm Hg) were risks factors associated
with subcapsular hematoma formation.
Although our small case number rendered statistical cor-
relation unsound, some extra clues can be provided. All of our
patients had obstructing proximal upper ureteral stones and
three of the affected kidneys were associated with thin renal
cortices. Long-term obstruction from the stone can result in
several technical challenges to the operation: (1) A more tor-
tuous ureter distal to the obstruction site, making it difficult to
advance the guidewire and increasing the risk of injury; (2) the
angulation of the ureter at the stone obstruction site can hin-
der the advancement of the ureteroscope, and a higher per-
fusion pressure through manual or mechanical pumping is
often needed to visualize the lumen; (3) a dilated pelvicaliceal
system with a reduced cortical thickness reduces the resis-
tance to raised intrarenal pressure and renders the capsule
more susceptible to injury.
This echoes the postulation of forniceal rupture by Bansal
and colleagues,4 and the observation of a forniceal rupture
during open exploration by Bai and associates.3 Bai and as-
sociates3 proposed that the post-URSL release of intrarenal
pressure could lead to sudden expansion and rupture of the
compressed renal parenchyma and vessels, causing bleeding
and hematoma formation within the renal capsule.3 This ef-
fect may be more prominent when the capillaries are thin or
even torn off to varying degrees in hydronephrotic kidneys.6
In our series, the same hydrostatic pressure of 80 cm H2O was
adopted for all patients, and no machine pumps were applied,
although there were variations in the irrigating pressure
provided by manual pressure. The current evidence suggests
that maintaining a steady and low intrarenal pressure is a
prerequisite to avoid intrarenal reflux and injury to the for-
nices. From our series, we suggest that extra care should be
taken to prevent high irrigating pressure in patients with
proximal ureteral stones with significant hydronephrosis and
a thin renal cortex.
Three of our four patients were obese, with a BMI > 25 kg/
m2. This may cause increased difficulty in guidewire place-
ment and ureteroscope advancement, thus increasing the
chance of injury to the system. Although the study by Bai and
coworkers3 did not show BMI as a risk factor for subcapsular
hematoma formation, we propose that caution should be ta-
ken in handling ureteroscopes in obese patients.
There is no standardized management of subcapsular he-
matoma after URSL, as there is for hematomas occurring after
SWL. Management was tailored according to each patient’s
clinical condition, mass effect of the hematoma, and clinical
progress with medical therapy, which were different in all
Table 2. Summary of Published Reports on Subcapsular Hematoma After Ureteroscopic Lithotripsy
Duffey 20085 Bansal 20104 Bai 20113 Current study
Number of patients 1 1 11 4
Age/sex 19/male 35/male Mean 44/82% male Mean 55/25% male
BMI / / Median 24.7 Mean 29.1
Ureteral stone location Proximal Proximal Proximal 21%
Middle: 29%
Distal: 50%
Proximal 100%
Mean stone size (range) 0.5 cm 1.0 cm 1.4 cm 1.6 cm
Hydronephrosis Moderate Moderate 8% mild
25% moderate
67% severe
25% mild
75% severe
Operative time range / / Range 32–50 min Range 30–150 min
Irrigation pressure / / 239 cmH2O 80 cmH2O
Presentation time < 12 hours 12 hours 4–10 hours 3 patients from day 1–2
1 patient on day 20
Presenting symptoms Loin pain,
vomiting
Loin pain, fever Loin pain,
hematuria, fever,
hypotension
Loin pain, fever, hematuria
Hb drop from baseline 2.2 g/dL / / 3–5g/dL
Packed cells transfusion 0 unit 0 unit Mean 2.8 units
(range 2–4)
2 units in all patients
Management Conservative Percutaneous
nephrostomy and
percutaneous
drainage of
hematoma
3 conservative
6 percutaneous
drainage
2 open drainage
1 Conservative
1 Angiogram
1 Percutaneous drainage
1 Open drainage
Hospital stay 2 days 9 days 10–35 days 12–59 days
BMI= body mass index; Hb=hemoglobin.
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patients in our series. In the 11 patients in the series by Bai and
colleagues,3 3 patients were treated conservatively, 6 patients
were treated with percutaneous drainage, and 2 patients had
open evacuation of the hematoma and repair of the ruptured
calix within a day of presenting with subcapsular hematoma.
There is no available protocol for the ideal timing of surgical
intervention, because the indication varies with the individual
condition. We suggest that for patients who present with
significant loin pain with or without fever after URSL, the
serum hemoglobin level should be monitored for any signif-
icant drop, and CT urographt should be performed if there is
any suspicion of hematoma development. Management of
post-URSL hematoma should include conservative, image-
guided drainage of the hematoma, angiography, emboliza-
tion, and finally open drainage as a last resort.
Conclusions
Post-URSL subcapsular hematoma is a rare but potentially
serious complication. A high index of suspicion is needed
when patients present with significant loin pain and fever
after URSL for obstructing proximal ureteral stones with thin
renal cortices. Management of post-URSL subcapsular he-
matomas needs to be customized for each patient.
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